Adicet Bio, Inc. (ACET) stock
ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
$2.93−0.06 (-2.01%)
Close on Nov 12, 2026Market cap $27.43MP/E –Yield –
Earnings
Adicet Bio's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 11, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$1.76
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Adicet Bio's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 11, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026after the close | – | – | -$1.76 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 5, 2026during market hours | – | – | -$1.99 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 13, 2026during market hours | – | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 12, 2026during market hours | – | – | -$2.94 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025during market hours | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 7, 2025during market hours | – | – | -$0.34 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 6, 2025during market hours | – | – | -$0.31 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 6, 2025during market hours | – | – | -$0.32 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 6, 2024during market hours | – | – | -$0.34 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 13, 2024before the open | – | – | -$0.33 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 14, 2024during market hours | – | – | -$0.35 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 19, 2024during market hours | – | – | -$0.69 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 8, 2023during market hours | – | – | -$1.16 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 9, 2023during market hours | – | – | -$0.75 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023during market hours | – | – | -$0.72 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 15, 2023during market hours | – | – | -$0.72 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 8, 2022during market hours | – | – | -$0.53 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 10, 2022before the open | – | – | -$0.56 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022during market hours | $24.99M | – | $0.10 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 15, 2022during market hours | $5.47M | – | -$0.47 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 10, 2021during market hours | $3.43M | – | -$0.44 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 12, 2021during market hours | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 17, 2021before the open | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 11, 2021during market hours | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 5, 2020during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Adicet Bio has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Adicet Bio puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Adicet Bio filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Update
- Update
- Results
- Results
- Results
- Update
- News
- Results
- News
- News
- News
- Results
See a number that looks wrong?